title: Early and intermediate term clinical outcome after multiple coronary stenting.
abstract: OBJECTIVE
  To examine the immediate and intermediate term clinical outcome of multiple coronary stenting.
  
  
  METHODS
  Consecutive patients were prospectively entered on a dedicated database. Follow up information was obtained from outpatient and telephone interviews with patients and family physicians.
  
  
  METHODS
  A tertiary referral centre.
  
  
  METHODS
  140 consecutive patients underwent multiple coronary stenting between April 1994 and November 1996. Most patients had unstable coronary syndromes.
  
  
  METHODS
  Death, cerebrovascular accidents, myocardial infarction (MI), coronary artery bypass surgery (CABG), and repeat angioplasty (PTCA).
  
  
  RESULTS
  The angiographic success rate was 100% and the clinical procedural success rate 93%. The mean (SD) follow up was 11.9 (7.2) months (range 2-32). The mean (SD) number of stents per patient was 2.4 (0.7). The mean (SD) number of lesions treated per patient was 1.4 (0.6). There were four in-hospital deaths (2.9%) and five patients (3.6%) had an MI before hospital discharge. All in-hospital deaths occurred in patients presenting with an acute MI and cardiogenic shock. Three patients (2.2%) had a late MI. One patient with stent thrombosis underwent emergency CABG. Three patients (2.2%) underwent late CABG. Eight patients (5.7%) had a repeat PTCA. Eighty three patients (61.5%) were asymptomatic at follow up and 121 (86.4%) were free from major clinical events.
  
  
  CONCLUSIONS
  In an era of increased operator experience, high pressure stent deployment, and reduced anticoagulation with antiplatelet treatment alone, multiple coronary stenting may be performed with a high procedural success rate and good intermediate term outcome.
authors.affiliation: Vancouver Hospital and Health Sciences Centre, University of British Columbia, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Chauhan
authors.forename: E
authors.initials: E
authors.lastname: Vu
authors.forename: D R
authors.initials: DR
authors.lastname: Ricci
authors.forename: C E
authors.initials: CE
authors.lastname: Buller
authors.forename: M D
authors.initials: MD
authors.lastname: Moscovich
authors.forename: S
authors.initials: S
authors.lastname: Monkman
authors.forename: I M
authors.initials: IM
authors.lastname: Penn
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000800:Angioplasty, Balloon; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000627:therapeutic use; D017023:Coronary Angiography; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000401:mortality / Q000601:surgery* / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011446:Prospective Studies; D015607:Stents; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin